BioMerieux Income from Continuous Operations 2017-2024 | BMXMF

BioMerieux income from continuous operations for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.

  • BioMerieux annual income from continuous operations for 2024 was $0.46B, a 31.67% increase from 2023.
  • BioMerieux annual income from continuous operations for 2023 was $0.349B, a 26.91% decline from 2022.
  • BioMerieux annual income from continuous operations for 2022 was $0.478B, a 32.46% decline from 2021.

BioMerieux Income from Continuous Operations 2017-2024 | BMXMF

  • BioMerieux annual income from continuous operations for 2024 was $0.46B, a 31.67% increase from 2023.
  • BioMerieux annual income from continuous operations for 2023 was $0.349B, a 26.91% decline from 2022.
  • BioMerieux annual income from continuous operations for 2022 was $0.478B, a 32.46% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$147.1B
CVS Health (CVS)$83B
Elevance Health (ELV)$78.1B
Cencora (COR)$57.6B
DiDi Global (DIDIY)$23.8B
Natera (NTRA)$22.3B
Labcorp Holdings (LH)$21.2B
EUROFINS SCIENT (ERFSF)$13.8B
Solventum (SOLV)$13.1B
CochLear (CHEOY)$12.8B
ICON (ICLR)$12.3B
Revvity (RVTY)$12.1B
Viatris (VTRS)$10.9B
Medpace Holdings (MEDP)$9.4B
Avantor (AVTR)$9.3B
Sonic Healthcare (SKHHY)$8.6B
HealthEquity (HQY)$8.4B
Charles River Laboratories (CRL)$8B
Caris Life Sciences,�Inc (CAI)$6.8B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5B
BrightSpring Health Services (BTSG)$3.7B
Sotera Health (SHC)$3.4B
Surgery Partners (SGRY)$2.9B
Alignment Healthcare (ALHC)$2.6B
Concentras Parent (CON)$2.6B
Organon (OGN)$2.6B
GeneDx Holdings (WGS)$2.5B
Ardent Health (ARDT)$2B
Progyny (PGNY)$2B